HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Brzozowski Selected Research

Gastric Fistula

11/2006Neural aspects of ghrelin-induced gastroprotection against mucosal injury induced by noxious agents.
12/2001Effect of central and peripheral actions of histamine and its metabolite N-alpha methyl histamine on gastric secretion and acute gastric lesions.
1/2001Involvement of gastrin in gastric secretory and protective actions of N-alpha-methyl histamine.
12/2000Helicobacter pylori infection delays healing of ischaemia-reperfusion induced gastric ulcerations: new animal model for studying pathogenesis and therapy of H. pylori infection.
6/2000Role of gastric acid secretion in progression of acute gastric erosions induced by ischemia-reperfusion into gastric ulcers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Brzozowski Research Topics

Disease

35Ulcer
12/2021 - 05/2000
28Stomach Ulcer (Gastric Ulcer)
02/2016 - 05/2000
17Inflammation (Inflammations)
06/2020 - 06/2001
15Ischemia
08/2011 - 05/2000
11Infections
10/2019 - 12/2000
11Hyperemia
10/2016 - 01/2000
8Peptic Ulcer (Peptic Ulcers)
12/2011 - 12/2003
7Neoplasms (Cancer)
04/2016 - 03/2003
6Colitis
06/2020 - 09/2007
6Carcinogenesis
12/2013 - 01/2003
5Hypoxia (Hypoxemia)
10/2017 - 03/2005
5Fistula
04/2016 - 01/2000
5Esophagitis
12/2014 - 09/2007
5Gastric Fistula
11/2006 - 06/2000
5Necrosis
09/2005 - 12/2000
4Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
08/2015 - 04/2011
4Gastroesophageal Reflux (GERD)
12/2014 - 02/2011
4Gastritis
12/2013 - 03/2003
4Obesity
08/2008 - 12/2005
3Non-alcoholic Fatty Liver Disease
02/2014 - 12/2010
3Diabetes Mellitus
10/2013 - 12/2004
3Duodenal Ulcer (Curling's Ulcer)
10/2011 - 12/2003
3Adenocarcinoma
08/2010 - 03/2003
2Peptic Esophagitis (Reflux Esophagitis)
12/2014 - 02/2011
2Alcoholic Fatty Liver
02/2014 - 04/2011
2Atrophic Gastritis
12/2013 - 09/2009
2Ulcerative Colitis
10/2012 - 06/2009
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
10/2012 - 12/2011

Drug/Important Bio-Agent (IBA)

22CytokinesIBA
06/2020 - 01/2000
18GastrinsIBA
12/2013 - 01/2000
17Acetic Acid (Vinegar)FDA LinkGeneric
02/2016 - 10/2000
16ProstaglandinsIBA
04/2016 - 10/2000
15Messenger RNA (mRNA)IBA
10/2019 - 01/2000
15Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2017 - 05/2000
14MelatoninIBA
12/2021 - 01/2004
13Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2021 - 10/2000
13Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
10/2017 - 10/2000
13Hormones (Hormone)IBA
12/2013 - 03/2004
13GhrelinIBA
12/2013 - 03/2004
12Proteins (Proteins, Gene)FDA Link
10/2019 - 12/2000
11LeptinIBA
10/2012 - 01/2000
10Capsaicin (Zostrix)FDA Link
10/2016 - 12/2001
10Histamine (Histamine Dihydrochloride)FDA Link
04/2016 - 06/2000
10Nitric Oxide Synthase (NO Synthase)IBA
12/2014 - 02/2001
9Peptides (Polypeptides)IBA
10/2013 - 01/2000
9Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2011 - 10/2000
9Cyclooxygenase 2 (Cyclooxygenase-2)IBA
08/2010 - 10/2000
9Ethanol (Ethyl Alcohol)IBA
12/2009 - 10/2000
9Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2009 - 12/2000
8Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
06/2011 - 12/2000
8Prostaglandins EIBA
03/2010 - 06/2001
7Proton Pump InhibitorsIBA
12/2013 - 06/2000
7Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
06/2011 - 06/2001
7AcidsIBA
06/2009 - 01/2000
6Phenobarbital (Luminal)FDA Link
02/2016 - 12/2000
6Indomethacin (Indometacin)FDA LinkGeneric
02/2016 - 03/2000
6Omeprazole (Prilosec)FDA LinkGeneric
10/2011 - 06/2000
6Interleukin-1beta (Interleukin 1 beta)IBA
08/2010 - 05/2000
6Transforming Growth Factor alpha (TGF-alpha)IBA
09/2006 - 12/2000
5NeuropeptidesIBA
12/2021 - 03/2004
5EnzymesIBA
10/2016 - 09/2005
5Dinoprostone (PGE2)FDA Link
10/2014 - 03/2000
5PPAR gammaIBA
10/2013 - 01/2003
5Cholecystokinin (Pancreozymin)IBA
03/2007 - 02/2001
4Anti-Bacterial Agents (Antibiotics)IBA
10/2019 - 12/2005
4InterleukinsIBA
10/2017 - 12/2000
4Tryptophan (L-Tryptophan)FDA Link
02/2014 - 08/2008
4Pepsin A (Pepsin)IBA
02/2011 - 01/2000
4Reactive Oxygen Species (Oxygen Radicals)IBA
12/2010 - 07/2001
4Epidermal Growth Factor (EGF)IBA
02/2008 - 01/2001
4Free RadicalsIBA
12/2007 - 05/2000
4rofecoxib (Vioxx)FDA Link
12/2004 - 12/2000
4Cyclooxygenase 1IBA
05/2003 - 01/2001
4N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA
06/2001 - 10/2000
3Oxygen (Dioxygen)IBA
12/2021 - 05/2000
3Biomarkers (Surrogate Marker)IBA
06/2020 - 03/2007
3Superoxide DismutaseIBA
10/2013 - 05/2000
3Streptozocin (Streptozotocin)FDA Link
10/2013 - 12/2004
3LipidsIBA
02/2012 - 03/2007
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2011 - 12/2001
3nitroxy-butyl-acetylsalicylic acidIBA
02/2011 - 07/2001
3LigandsIBA
08/2010 - 01/2003
3Insulin (Novolin)FDA Link
12/2007 - 12/2004
3Protein Isoforms (Isoforms)IBA
09/2005 - 06/2001
3Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
03/2003 - 01/2000
3AntibodiesIBA
09/2001 - 12/2000
3Ranitidine (Zantac)FDA LinkGeneric
09/2001 - 06/2000
2AdiponectinIBA
06/2020 - 08/2008
2AdipokinesIBA
06/2020 - 04/2013
2Interleukin-10 (Interleukin 10)IBA
10/2017 - 10/2014
2Naproxen (Naprosyn)FDA LinkGeneric
10/2017 - 10/2000
2Interleukin-6 (Interleukin 6)IBA
10/2017 - 10/2014
2AngiotensinsIBA
08/2016 - 02/2016
2Losartan (Cozaar)FDA LinkGeneric
08/2016 - 02/2016
2angiotensin I (1-7)IBA
02/2016 - 12/2014
2oxidized low density lipoproteinIBA
02/2014 - 03/2007
2OrexinsIBA
10/2013 - 12/2005

Therapy/Procedure

14Therapeutics
06/2020 - 12/2000
4Vagotomy
11/2006 - 12/2001
2Lasers (Laser)
12/2013 - 10/2010